ATE505463T1 - Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten - Google Patents
Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonistenInfo
- Publication number
- ATE505463T1 ATE505463T1 AT03010776T AT03010776T ATE505463T1 AT E505463 T1 ATE505463 T1 AT E505463T1 AT 03010776 T AT03010776 T AT 03010776T AT 03010776 T AT03010776 T AT 03010776T AT E505463 T1 ATE505463 T1 AT E505463T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- groups
- receptor antagonists
- atoms
- benzodiazepine derivatives
- Prior art date
Links
- 229940122623 CCK receptor antagonist Drugs 0.000 title 1
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title 1
- 150000001557 benzodiazepines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- DXMNJSHCPPFVHG-UHFFFAOYSA-N (hydroxyamino) nitroformate Chemical compound ONOC(=O)[N+]([O-])=O DXMNJSHCPPFVHG-UHFFFAOYSA-N 0.000 abstract 1
- 229940123406 CCK B receptor antagonist Drugs 0.000 abstract 1
- 108010089448 Cholecystokinin B Receptor Proteins 0.000 abstract 1
- 102000052874 Gastrin receptors Human genes 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000005518 carboxamido group Chemical group 0.000 abstract 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9204221A GB2264492B (en) | 1992-02-27 | 1992-02-27 | Benzodiazepine derivatives |
| GB929212740A GB9212740D0 (en) | 1992-02-27 | 1992-06-16 | Benzodiazephine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE505463T1 true ATE505463T1 (de) | 2011-04-15 |
Family
ID=10711162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03010776T ATE505463T1 (de) | 1992-02-27 | 1993-02-26 | Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1342719B1 (de) |
| KR (1) | KR100282587B1 (de) |
| AT (1) | ATE505463T1 (de) |
| DE (1) | DE69334353D1 (de) |
| ES (1) | ES2364637T3 (de) |
| GB (2) | GB2264492B (de) |
| ZA (1) | ZA931381B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9315494D0 (en) * | 1993-07-27 | 1993-09-08 | Springer Caroline | Improvements relating to prodrugs |
| GB2282594A (en) * | 1993-08-25 | 1995-04-12 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
| GB2282595A (en) * | 1993-08-25 | 1995-04-12 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
| GB201414116D0 (en) * | 2014-08-08 | 2014-09-24 | Trio Medicines Ltd | Benzodiazepine derivatives |
| GB201513979D0 (en) | 2015-08-07 | 2015-09-23 | Trio Medicines Ltd | Synthesis of benzodiazepine derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
| CA2026856A1 (en) * | 1989-10-05 | 1991-04-06 | Mark G. Bock | 3-substituted-1,4-benzodiazepines useful as oxytocin |
| CA2032226A1 (en) * | 1989-12-18 | 1991-06-19 | Mark G. Bock | Benzodiazepine analogs |
| IL96613A0 (en) * | 1989-12-18 | 1991-09-16 | Merck & Co Inc | Pharmaceutical compositions containing benzodiazepine analogs |
| IE904560A1 (en) * | 1989-12-18 | 1991-06-19 | Merck & Co Inc | New benzodiazepine analogs |
| US4994258A (en) | 1990-03-05 | 1991-02-19 | Merck & Co., Inc. | Gamma emitting, CCK-A antagonists for pancreatic imaging |
| US5218115A (en) * | 1991-04-10 | 1993-06-08 | Merck & Co., Inc. | Cholecystokinin antagonists |
| US5218114A (en) * | 1991-04-10 | 1993-06-08 | Merck & Co., Inc. | Cholecystokinin antagonists |
| FR2682381B1 (fr) * | 1991-10-10 | 1995-04-07 | Rhone Poulenc Rorer Sa | Derives de benzodiazepine, leur preparation et les medicaments les contenant. |
| EP0538945A1 (de) * | 1991-10-24 | 1993-04-28 | Glaxo Group Limited | Benzodiazepinderivate, und ihre Verwendung als Gastrin und/oder Cholecystokinin-Antagonisten |
-
1992
- 1992-02-27 GB GB9204221A patent/GB2264492B/en not_active Revoked
- 1992-06-16 GB GB929212740A patent/GB9212740D0/en active Pending
-
1993
- 1993-02-26 EP EP03010776A patent/EP1342719B1/de not_active Expired - Lifetime
- 1993-02-26 ZA ZA931381A patent/ZA931381B/xx unknown
- 1993-02-26 AT AT03010776T patent/ATE505463T1/de not_active IP Right Cessation
- 1993-02-26 KR KR1019940702875A patent/KR100282587B1/ko not_active Expired - Fee Related
- 1993-02-26 DE DE69334353T patent/DE69334353D1/de not_active Expired - Lifetime
- 1993-02-26 ES ES03010776T patent/ES2364637T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2364637T3 (es) | 2011-09-08 |
| ZA931381B (en) | 1993-12-15 |
| EP1342719B1 (de) | 2011-04-13 |
| GB9212740D0 (en) | 1992-07-29 |
| KR100282587B1 (ko) | 2001-02-15 |
| GB9204221D0 (en) | 1992-04-08 |
| GB2264492A8 (de) | 1996-07-29 |
| KR950700225A (ko) | 1995-01-16 |
| GB2264492B (en) | 1996-09-25 |
| DE69334353D1 (de) | 2011-05-26 |
| EP1342719A1 (de) | 2003-09-10 |
| GB2264492A (en) | 1993-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800908A1 (ru) | Производные индола, полезные в качестве антагонистов рецептора эндотелина | |
| DE69131581D1 (de) | 2-Oxindolderivate als Tyrosinekinaseinhibitoren | |
| NO986055D0 (no) | Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat | |
| DK0583485T3 (da) | Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger | |
| CA2129990A1 (en) | Benzodiazepin derivatives useful as cck-receptor antagonists | |
| ES2104865T3 (es) | Nuevos derivados de n-ciclohexilbenzamidas, sus preparaciones y sus aplicaciones terapeuticas. | |
| ATE224371T1 (de) | N-substituierte beta-aryl und beta-heteroaryl- alpha-cyamoacrylamidderivate als tyrosine kinase inhibitoren | |
| ATE228364T1 (de) | Indolalkaloide als antientzündliche wirkstoffe | |
| HU9801950D0 (en) | 2-(arylphenyl)-amino-imidazoline derivatives | |
| NO960747L (no) | Benzodiazpinderivater | |
| EP0591529A4 (de) | Neues benzodiazepinderivat. | |
| ATE505463T1 (de) | Benzodiazepin-derivate, verwendbar als cck- rezeptor antagonisten | |
| ATE219486T1 (de) | Trizyklische indol-2-carbonsäure derivate als selektive nmda rezeptor antagonisten | |
| PT728748E (pt) | Novos derivados da benzodiazepina | |
| NO933115L (no) | 3-oksadiazolyl-1,6-naftyridinderivater | |
| EA199800720A1 (ru) | Гетероциклические производные эрголина в качестве лигандов 5-htia рецептора | |
| DK369289D0 (da) | Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler | |
| PT92494A (pt) | Processo para a preparacao de novos derivados do indol | |
| NZ221004A (en) | 2,6-piperazinediones and pharamceutical compositions | |
| TW327636B (en) | Heterocyclic ring-fused pyrimidine derivatives | |
| NO308304B1 (no) | Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst | |
| CO4920233A1 (es) | Acidos aminobutiricos gamma substituidos como agentes farmaceuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |